CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government

Ce qui s'est passé

CVS Pharmacy Inc., a Rhode Island-based pharmacy chain, and its related corporate entities (collectively, CVS) have agreed to pay $315 million to resolve allegations that, from October 17, 2013 through December 2, 2025, CVS illegally filled prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA), and then sought payment for many of those invalid prescriptions...

Pourquoi c'est important

The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.

Entités concernées

Voir les preuves

2 articles · 1 publication d'origine · 1 independantes

1. U.S. Department of JusticeSource primaire · Confirme · EN · 100%
   CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government ↗13 oct. 2026, 08:00
2. U.S. Department of JusticeSource primaire · Confirme · EN · 80%
   CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government ↗13 oct. 2026, 08:00

Affirmations

• CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government Observé

Divergences

Aucune divergence importante détectée dans les preuves disponibles.

Chronologie

1. 13 octobre 2026 à 08:00Premier signalement

Mouvement de marché suivant l'événement

La réaction du marché n'est pas encore disponible pour cet actif et cette fenêtre.

Explication des scores